Countries rushed to sign contracts to prepare for a surge of cases
PHOTO
Pfizer Inc on Thursday reaffirmed the combined 2022 sales forecast of $54 billion for its COVID-19 vaccine and pill, as countries rushed to sign contracts to prepare for a surge of cases in the fall season.
(Reporting by Manas Mishra in Bengaluru; Editing by Arun Koyyur)
Reuters
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
